Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit

The frequent alterations of the PI3K/Akt/mTOR-growth signaling pathway are proposed mechanisms for resistance to endocrine therapy in breast cancer, partly through regulation of estrogen receptor α (ER) activity. Reliable biomarkers for treatment prediction are required for improved individualized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bostner, Josefine, Karlsson, Elin, Pandiyan, Muneeswaran J., Westman, Hanna, Skoog, Lambert, Fornander, Tommy, Nordenskjöld, Bo, Stål, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539073/
https://www.ncbi.nlm.nih.gov/pubmed/23242584
http://dx.doi.org/10.1007/s10549-012-2376-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539073/
https://www.ncbi.nlm.nih.gov/pubmed/23242584
http://dx.doi.org/10.1007/s10549-012-2376-y

Ejemplares similares